TY  - JOUR
AU  - Guasch-Ferré, Marta
AU  - Ruiz-Canela, Miguel
AU  - Li, Jun
AU  - Zheng, Yan
AU  - Bulló, Mònica
AU  - Wang, Dong D
AU  - Toledo, Estefanía
AU  - Clish, Clary
AU  - Corella, Dolores
AU  - Estruch, Ramon
AU  - Ros, Emilio
AU  - Fitó, Montserrat
AU  - Arós, Fernando
AU  - Fiol, Miquel
AU  - Lapetra, José
AU  - Serra-Majem, Lluís
AU  - Liang, Liming
AU  - Papandreou, Christopher
AU  - Dennis, Courtney
AU  - Martínez-González, Miguel A
AU  - Hu, Frank B
AU  - Salas-Salvadó, Jordi
PY  - 2019
DO  - 10.1210/jc.2018-01000
UR  - http://hdl.handle.net/10668/13180
T2  - The Journal of clinical endocrinology and metabolism
AB  - The potential associations between acylcarnitine profiles and incidence of type 2 diabetes (T2D) and whether acylcarnitines can be used to improve diabetes prediction remain unclear. To evaluate the associations between baseline and 1-year changes in...
LA  - en
KW  - Aged
KW  - Aged, 80 and over
KW  - Biomarkers
KW  - Cardiovascular Diseases
KW  - Carnitine
KW  - Case-Control Studies
KW  - Diabetes Mellitus, Type 2
KW  - Diet, Mediterranean
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Incidence
KW  - Male
KW  - Metabolomics
KW  - Middle Aged
KW  - Prognosis
KW  - Prospective Studies
KW  - ROC Curve
KW  - Risk Factors
TI  - Plasma Acylcarnitines and Risk of Type 2 Diabetes in a Mediterranean Population at High Cardiovascular Risk.
TY  - research article
VL  - 104
ER  -